Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “EnGeneIC Molecular Delivery Pty Ltd”

37 pharma patents match "EnGeneIC Molecular Delivery Pty Ltd" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 37
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 37 pharmaceutical patents matching "EnGeneIC Molecular Delivery Pty Ltd" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

37 results for “EnGeneIC Molecular Delivery Pty Ltd” · 30,257 patents in full index Clear search

  1. US 12414968

    Compositions comprising bacterially derived minicells and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12357687

    Compositions and vaccines for treating and/or preventing viral infections, and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  3. US 12337033

    Encapsulated glycolipid antigens for treatment of neoplastic diseases

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  4. US 11964021

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  5. US 11504402

    Compositions comprising bacterially derived minicells and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  6. US 11485976

    Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  7. US 11357860

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  8. US 11147883

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  9. US 11052157

    Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  10. US 10994014

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  11. US 10799461

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  12. US 10583200

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  13. US 10500277

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    EnGeneIC Molecular Delivery Pty Ltd · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted
  14. US 10441546

    Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  15. US 10426736

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  16. US 10383827

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  17. US 10328159

    Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  18. US 10098847

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  19. US 10076545

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  20. US 9987377

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  21. US 9878043

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  22. US 9867785

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted
  23. US 9844598

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  24. US 9730897

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted